Skip to main content

Advertisement

SpringerLink
Log in

Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objectives of this study are autoinflammatory syndromes which are usually characterized by repeated attacks of fever, especially in children. The presentation of these diseases, however, varies between entities and between patients of a particular syndrome. We report a 16-year-old female patient, who suffered from periodic erythema and myositis/fasciitis. She experienced at least nine attacks of dermatitis and myositis, while no fever episodes were noted over a 3-year period. A delay of puberty with amenorrhea and a short stature were also present. Laboratory investigations consistently showed markedly increased inflammatory parameters (especially a high serum amyloid A) and dysproteinemia. Because the patient′s mother complained about chronic and periodic abdominal pain with also persistently elevated inflammatory parameters, the differential diagnosis included hereditary disorders resulting in chronic inflammation. The diagnosis of an inherited tumor necrosis factor receptor (TNFR) 1-associated periodic syndrome (TRAPS) was confirmed by genetic analyses. Long-term anti-inflammatory treatment with etanercept resulted in a significant clinical improvement and reduction of the inflammatory parameters ESR, CRP, interleukin-6, TNF-α, and soluble TNF-α receptor 1, but not of interleukin-12. Monitoring of the cytokine profile suggested partial effectiveness of etanercept in the treatment of TRAPS. Hereditary fever syndromes have to be considered in case of chronic unexplained inflammation even if fever is no presenting symptom.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Blanco P, Palucka AK, Pascual V, Banchereau J (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19:41–52

    Article  CAS  PubMed  Google Scholar 

  2. Dode C, Andre M, Bienvenu T, Hausfater P, Pecheux C, Bienvenu J, Lecron JC, Reinert P, Cattan D, Piette JC, Szajnert MF, Delpech M, Grateau G (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46:2181–2188

    Article  CAS  PubMed  Google Scholar 

  3. Dode C, Cuisset L, Delpech M, Grateau G (2003) TNFRSF1A-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS) and renal amyloidosis. J Nephrol 16:435–437

    CAS  PubMed  Google Scholar 

  4. Drewe E, Huggins ML, Morgan AG, Cassidy MJ, Powell RJ (2004) Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford) 43:1405–1408

    Article  CAS  Google Scholar 

  5. Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ (2003) Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford) 42:235–239

    Article  CAS  Google Scholar 

  6. Gattorno M, Pelagatti MA, Meini A, Obici L, Barcellona R, Federici S, Buoncompagni A, Plebani A, Merlini G, Martini A (2008) Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 58:1516–1520

    Article  CAS  PubMed  Google Scholar 

  7. Grateau G, Jeru I, Rouaghe S, Cazeneuve C, Ravet N, Duquesnoy P, Cuisset L, Dode C, Delpech M, Amselem S (2005) Amyloidosis and auto-inflammatory syndromes. Curr Drug Targets Inflamm Allergy 4:57–65

    Article  CAS  PubMed  Google Scholar 

  8. Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, Hospach T, Huppertz HI, Keitzer R, Kuster RM, Michels H, Moebius D, Rogalski B, Thon A (2004) The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63:1638–1644

    Article  CAS  PubMed  Google Scholar 

  9. Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368

    Article  CAS  Google Scholar 

  10. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL (2003) The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 15:61–69

    Article  CAS  PubMed  Google Scholar 

  11. Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM, Kastner DL, Screaton GR, Siegel RM (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108:1320–1327

    Article  CAS  PubMed  Google Scholar 

  12. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O’Shea JJ, Kastner DL (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133–144

    Article  CAS  PubMed  Google Scholar 

  13. Nowlan ML, Drewe E, Bulsara H, Esposito N, Robins RA, Tighe PJ, Powell RJ, Todd I (2006) Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford) 45:31–37

    Article  CAS  Google Scholar 

  14. Rebelo SL, Bainbridge SE, Amel-Kashipaz MR, Radford PM, Powell RJ, Todd I, Tighe PJ (2006) Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum 54:2674–2687

    Article  CAS  PubMed  Google Scholar 

  15. Sacre K, Brihaye B, Lidove O, Papo T, Pocidalo MA, Cuisset L, Dode C (2008) Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy. J Rheumatol 35:357–358

    CAS  PubMed  Google Scholar 

  16. Stojanov S, Lohse P, Hoffmann F, Renner ED, Zellerer S, Kery A, Shin YS, Haas D, Hoffmann GF, Belohradsky BH (2004) Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum 50:1951–1958

    Article  CAS  PubMed  Google Scholar 

  17. Stojanov S, Lohse P, McDermott MF, Renner ED, Kery A, Mirakian R, Hammond LJ, Aganna E, Hoffmann F, Zellerer S, Belohradsky BH (2004) Periodic fever due to a novel TNFRSF1A mutation in a heterozygous Chinese carrier of MEFV E148Q. Rheumatology (Oxford) 43:526–527

    Article  CAS  Google Scholar 

  18. Stojanov S, McDermott MF (2005) The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med 7:1–18

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. S. Stojanov

    Present address: Genetics and Genomics Branch, NIAMS, NIH, Bethesda, USA

Authors and Affiliations

  1. Section of Pediatric Rheumatology and Osteology, Children‘s Hospital, University of Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany

    H. Morbach, P. Richl & Hermann J. Girschick

  2. Children’s Hospital, University of Munich, Munich, Germany

    S. Stojanov

  3. Department of Clinical Chemistry-Großhadern, University of Munich, Munich, Germany

    P. Lohse

Authors
  1. H. Morbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Richl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Stojanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Lohse
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hermann J. Girschick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hermann J. Girschick.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morbach, H., Richl, P., Stojanov, S. et al. Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment. Rheumatol Int 30, 207–212 (2009). https://doi.org/10.1007/s00296-009-0937-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-0937-0

Keywords

Search

Navigation